Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.
We performed a meta-analysis of 3 genome-wide association studies to identify additional common variants influencing chronic lymphocytic leukemia (CLL) risk. The discovery phase was composed of genome-wide association study data from 1121 cases and 3745 controls. Replication analysis was performed i...
Main Authors: | Slager, S, Skibola, C, Bernardo, D, Conde, L, Broderick, P, McDonnell, S, Goldin, L, Croft, N, Holroyd, A, Harris, S, Riby, J, Serie, D, Kay, N, Call, T, Bracci, P, Halperin, E, Lanasa, M, Cunningham, J, Leis, J, Morrison, V, Spector, L, Vachon, C, Shanafelt, T, Strom, S, Camp, N |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Clinical and molecular delineation of the 17q21.31 microdeletion syndrome.
by: Koolen, D, et al.
Published: (2008) -
Clinical and molecular delineation of the 17q21.31 microdeletion syndrome
by: Koolen, D, et al.
Published: (2008) -
BAK-up: the receptor kinase BAK-TO-LIFE 2 enhances immunity when BAK1 is lacking
by: Vahid Fallahzadeh-Mamaghami, et al.
Published: (2023-09-01) -
Tyrosine dephosphorylation is required for Bak activation in apoptosis.
by: Fox, J, et al.
Published: (2010) -
Tyrosine dephosphorylation is required for Bak activation in apoptosis
by: Fox, J, et al.
Published: (2010)